Cancer Incidence and Mortality for Essex County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 272.2 472.6 446.8-499.8 139.8 505.6 467.5-546.2 132.4 458.7 422.1-498.1 102.2 166.6 152.2-182.3 55.8 201.8 178.3-227.8 46.4 141.9 123.6-162.8
Oral cavity and pharynx 7.6 13.1 9.1-18.4 5.6 19.3 12.6-28.9 2.0 6.5 3.0-13.3 2.6 4.5 2.4-8.2 1.8 6.6 2.9-13.2 0.8 2.7 0.7-8.5
Esophagus 2.2 3.7 1.8-7.0 1.4 4.6 1.8-10.5 0.8 2.6 0.7-8.1 2.6 4.1 2.1-7.4 1.8 6.0 2.7-12.2 0.8 2.3 0.6-7.6
Stomach 2.8 4.7 2.5-8.3 1.6 5.9 2.5-12.4 1.2 3.7 1.3-9.5 0.2 0.4 0.0-2.8 0.0 0.0 0.0-4.1 0.2 0.7 0.0-5.6
Colorectal 22.2 38.7 31.6-47.2 11.4 43.8 33.0-57.4 10.8 35.9 26.2-48.6 9.2 15.4 11.2-21.0 4.4 16.5 10.2-25.6 4.8 15.0 9.3-23.8
Colon excluding rectum 15.2 26.4 20.5-33.6 6.4 24.5 16.7-35.3 8.8 29.6 20.7-41.5 7.8 13.0 9.1-18.2 3.4 12.7 7.3-21.0 4.4 14.0 8.4-22.6
Rectum & rectosigmoid 7.0 12.4 8.5-17.6 5.0 19.3 12.4-29.1 2.0 6.3 2.9-12.8 1.4 2.5 1.0-5.6 1.0 3.8 1.2-9.6 0.4 1.0 0.1-5.9
Liver / intrahepatic bile duct 4.4 6.7 4.2-10.7 3.2 10.2 5.7-17.4 1.2 3.8 1.4-9.5 3.8 5.7 3.4-9.4 3.4 10.5 6.0-17.7 0.4 1.3 0.2-6.3
Pancreas 8.0 13.3 9.5-18.6 4.0 14.1 8.5-22.5 4.0 12.6 7.7-20.6 6.8 11.1 7.7-16.0 4.0 13.8 8.3-22.1 2.8 8.6 4.7-15.6
Larynx 1.8 3.4 1.5-7.1 1.8 6.8 3.0-13.9 0.0 0.0 0.0-4.6 0.4 1.0 0.1-3.9 0.4 1.8 0.2-7.3 0.0 0.0 0.0-4.6
Lung and bronchus 44.8 72.3 63.0-82.8 23.8 80.9 66.8-97.6 21.0 66.8 54.4-81.8 29.4 47.2 39.8-55.9 15.8 56.0 44.1-70.5 13.6 41.0 31.7-53.0
Melanoma of the skin 13.2 24.1 18.4-31.2 6.6 24.2 16.5-34.8 6.6 26.3 17.5-38.4 2.6 4.4 2.3-8.0 2.0 8.3 4.0-15.8 0.6 1.5 0.3-6.4
Female breast             36.2 128.4 109.1-150.5             5.8 18.0 12.0-26.9
Cervix uteri             2.0 9.8 4.3-19.3             0.2 0.6 0.0-5.3
Corpus uterus and NOS             8.6 26.5 19.0-36.7             1.8 5.0 2.3-10.9
Ovary             2.6 8.7 4.4-16.3             1.6 5.6 2.2-12.6
Prostate       26.0 84.6 70.4-101.3             3.4 12.9 7.4-21.2      
Testis       1.2 7.1 2.6-15.4             0.0 0.0 0.0-4.1      
Urinary bladder (incl. in situ) 16.4 27.3 21.6-34.3 13.8 51.6 39.9-66.0 2.6 7.3 3.9-13.8 3.0 5.0 2.7-8.7 2.0 7.8 3.7-15.0 1.0 2.4 0.8-7.6
Kidney and renal pelvis 8.0 14.3 10.0-20.0 3.8 14.2 8.3-23.1 4.2 13.8 8.2-22.4 2.0 3.2 1.5-6.3 1.4 4.8 1.9-10.9 0.6 1.8 0.4-6.9
Brain and other central nervous system 5.0 10.0 6.2-15.4 2.8 12.4 6.4-21.9 2.2 7.8 3.7-15.3 4.4 7.2 4.4-11.3 2.2 8.0 3.9-15.2 2.2 6.3 3.1-12.5
Thyroid 6.6 15.6 10.5-22.3 1.0 4.5 1.3-11.1 5.6 28.4 18.3-42.2 0.6 1.0 0.2-3.6 0.0 0.0 0.0-4.1 0.6 2.0 0.4-7.3
Hodgkin lymphoma 1.2 3.4 1.2-7.5 1.0 5.3 1.6-12.6 0.2 1.4 0.0-7.3 0.0 0.0 0.0-2.1 0.0 0.0 0.0-4.1 0.0 0.0 0.0-4.6
Non-Hodgkin lymphomas 12.2 20.9 15.8-27.4 7.8 28.8 20.1-40.3 4.4 13.9 8.6-22.1 2.8 4.2 2.3-7.6 1.8 6.4 2.9-13.0 1.0 2.6 0.8-7.8
Myeloma 4.4 7.1 4.4-11.3 1.8 6.3 2.8-12.9 2.6 8.4 4.4-15.6 2.0 3.4 1.6-6.8 0.8 3.2 0.8-8.9 1.2 3.8 1.3-9.7
Leukemias 9.6 18.0 12.9-24.6 6.6 25.5 17.2-36.8 3.0 11.1 5.7-19.8 3.8 6.2 3.6-10.2 2.0 7.1 3.4-13.9 1.8 6.0 2.5-13.0

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.